{name}
{subtitle}
Immunotherapy With Nivolumab and Ipilimumab Followed by Nivolumab or Nivolumab With Cabozantinib for Patients With Advanced Kidney Cancer, The PDIGREE Study
city
~36 mi. (West Branch, Michigan, +523 more cities)
facility
Saint Mary's Oncology/Hematology Associates of West Branch
drug
cabozantinib, +2 more drugs
drug type
immunotherapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~36 mi. (West Branch, Michigan, +825 more cities)
facility
Saint Mary's Oncology/Hematology Associates of West Branch
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
city
~36 mi. (West Branch, Michigan, +327 more cities)
facility
Saint Mary's Oncology/Hematology Associates of West Branch
drug
bortezomib, +3 more drugs
drug type
chemotherapy, +3 more types
S0820, Adenoma and Second Primary Prevention Trial
city
~36 mi. (West Branch, Michigan, +616 more cities)
facility
Saint Mary's Oncology/Hematology Associates of West Branch
condition
Colon Carcinoma, +1 more condition
drug
eflornithine, +2 more drugs
drug type
chemotherapy, +1 more type